Who may participate

Each clinical study has its own guidelines for who may participate, called eligibility criteria. These factors can include your age, sex, overall health, type and stage of disease, and personal treatment history. However, only the research study staff can determine if you qualify to enroll in the study.

Condition
Colitis, Ulcerative
Sex
Male or Female
Age
2 - 11 years
Healthy participants
No
Visit ClinicalTrials.gov for more information

Eligibility criteria

Study overview

The purpose of this study is to determine the safety, efficacy, and pharmacokinetics (PK) of etrasimod for the treatment of moderately to severely active ulcerative colitis in pediatrics participants (≥ 2 years up to < 12 years of age). Participants who will complete the total 52-week treatment period will have the opportunity to continue in a Long-Term Extension (LTE) Period of up to 4 years (5 years after study enrollment).

View locations for this study

Find the closest location, your results will be shown below
Find the closest location
    Miles
    0500

    Nearest Locations found

    3 sites found

    Japanese Red Cross Kumamoto Hospital

    Kumamoto, Japan, 861-8520
    Site Info

    Juntendo University Hospital

    Bunkyo-ku, Tokyo, Japan, 113-8431
    Site Info

    Saitama Prefectural Children's Medical Center

    Saitama-shi, Saitama, Japan, 330-8777
    Site Info
    • Recruitment Status
    • Site details
    • Study Contact
    • Clinical Trials ID

    Study Locations

    View locations for this studyFind the closest location, your results will be shown belowFind the closest location